María Celeste García-Frontini Nieto

María Celeste García-Frontini Nieto

Auto-generated profile, based on publicly available information

María Celeste García-Frontini Nieto

Environmental Factors in Degenerative Diseases Research Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2022 in Biology
Verified
Journal Article
Open access
PDF file
MDMaría Inmaculada Domínguez-Mozo
María Inmaculada Domínguez-Mozo
MNMaría Celeste García-Frontini Nieto
María Celeste García-Frontini Nieto
MGMaría Isabel Gómez-Calcerrada
María Isabel Gómez-Calcerrada
SPSilvia Pérez-Pérez
Silvia Pérez-Pérez
GAGarcia Martinez Angel
Garcia Martinez Angel
Roberto Álvarez-LafuenteRoberto Álvarez-Lafuente
Roberto Álvarez-Lafuente
Although impaired mitochondrial function has been proposed as a hallmark of multiple sclerosis (MS) disease, few studies focus on the mitochondria of immune cells. We aimed to compare the mitochondrial function of the peripheral blood mononuclear cells (PBMCs) from MS patients with (M+) and without (M−) lipid-specific oligoclonal immunoglobulin M bands (LS-OCMB), and healthydonors (HD). We conducted an exploratory cross-sectional study with 19 untreated MS patients (M+ = 9 and M− = 10) and 17 HDs. Mitochondrial superoxide anion production and mitochondrial mass in PBMCs were assessed without and with phytohemagglutinin by flow cytometry. The PBMCs’ mitochondrial function was analyzed using Seahorse technology. Superoxide anion production corrected by the mitochondrial mass was higher in MS patients compared with HDs (p = 0.011). Mitochondrial function from M+ patients showed some impairments compared with M− patients. Without stimulus, we observed higher proton leak (p = 0.041) but lower coupling efficiency (p = 0.041) in M+ patients; and under stimulation, lower metabolic potential ECAR (p = 0.011), and lower stressed OCR/ECAR in the same patients. Exclusively among M+ patients, we described a higher mitochondrial dysfunction in the oldest ones. The mitochondrial impairments found in the PBMCs from MS patients, specifically in M+ patients, could help to better understand the disease’s physiopathology.